Global Infrastructure Partners Transition Fund-C2, SCSp has filed an amendment to its private equity offering, indicating a significant step in its fundraising efforts. The amendment clarifies the status of the firm’s capital raising activities and regulatory compliance, which is crucial for attracting further investments.
This filing is particularly notable as it reveals that the fund has successfully raised approximately $911.6 million to date. This amount reflects strong investor interest in the fund, which is categorized under pooled investment funds.
Background
Global Infrastructure Partners Transition Fund-C2, SCSp is a limited partnership based in Luxembourg. The company focuses on pooled investment funds, specifically in the private equity sector. According to recent filings, the firm is registered under the SEC with a central index key (CIK) of 0002088459. The latest filing was made on November 4, 2026, as an amendment to a previous offering.
What the Filing Says
The recent amendment, filed under the accession number 0002088459-26-000001, provides updates on the fund's compliance with SEC regulations. It states, "Rule 506(b) provides a 'safer harbor' for a private offering." This highlights the fund's adherence to regulatory standards, which is essential for maintaining investor confidence.
Impact
The amendment may affect various stakeholders, including investors and regulatory bodies. It confirms that the fund has not accepted investments from non-accredited investors, ensuring compliance with SEC guidelines. The total offering amount remains indefinite, indicating ongoing fundraising efforts.
What's Next
The filing does not say what happens next, leaving the future steps of the fundraising process unclear. However, the successful raising of funds to date suggests that the firm may continue to attract interest in the private equity market.
Read Next
UBS AG files pricing supplement for crude oil-linked ETNs
JPMorgan Chase Financial Co. files for new callable securities
JPMorgan Chase Financial Co. files pricing supplement for notes
HSBC USA Inc offers new investment notes linked to ETF
POMDOCTOR Ltd Converts Debt to Equity in Major Agreement
Quoin Pharmaceuticals Enters Sales Agreement with Leerink






